145 related articles for article (PubMed ID: 10515442)
1. Difference in the incidence of cough induced by angiotensin converting enzyme inhibitors: a comparative study using imidapril hydrochloride and enalapril maleate.
Saruta T; Arakawa K; Iimura O; Abe K; Matsuoka H; Nakano T; Nakagawa M; Ogihara T; Kajiyama G; Hiwada K; Fujishima M; Nakajima M
Hypertens Res; 1999 Sep; 22(3):197-202. PubMed ID: 10515442
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the incidence of imidapril and enalapril induced cough.
Boonyapisit W; Tresukosol D
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S48-53. PubMed ID: 20364557
[TBL] [Abstract][Full Text] [Related]
3. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
[TBL] [Abstract][Full Text] [Related]
4. Cough-challenge trial with a new angiotensin-converting enzyme inhibitor, imidapril.
Shionoiri H; Takasaki I; Minamisawa K; Ueda S; Kihara M; Shindo K; Hiroto S; Sugimoto K; Himeno H; Naruse M; Nagamochi I; Yasuda G
J Clin Pharmacol; 1998 May; 38(5):442-6. PubMed ID: 9602958
[TBL] [Abstract][Full Text] [Related]
5. Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is.
Tumanan-Mendoza BA; Dans AL; Villacin LL; Mendoza VL; Rellama-Black S; Bartolome M; Ragual J; Flor B; Valdez J
J Clin Epidemiol; 2007 Jun; 60(6):547-53. PubMed ID: 17493508
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Rake EC; Breeze E; Fletcher AE
J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic effect of imidapril on stroke in stroke-prone spontaneously hypertensive rats.
Ogiku N; Sumikawa H; Hashimoto Y; Ishida R
Stroke; 1993 Feb; 24(2):245-52. PubMed ID: 8421827
[TBL] [Abstract][Full Text] [Related]
8. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
Hosoya K; Ishimitsu T
Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
[TBL] [Abstract][Full Text] [Related]
9. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
Breeze E; Rake EC; Donoghue MD; Fletcher AE
J Hum Hypertens; 2001 Dec; 15(12):857-62. PubMed ID: 11773988
[TBL] [Abstract][Full Text] [Related]
10. Different effects of imidapril and enalapril on aminopeptidase P activity in the mouse trachea.
Sakamoto K; Sugimoto K; Sudoh T; Fujimura A
Hypertens Res; 2005 Mar; 28(3):243-7. PubMed ID: 16097368
[TBL] [Abstract][Full Text] [Related]
11. Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs.
Nishiyama S; Kanno K; Yoneda H; Yano K; Yamaguchi I
Arzneimittelforschung; 1992 Apr; 42(4):451-6. PubMed ID: 1322673
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of imidapril in patients with essential hypertension: a double-blind comparison with captopril.
Huang PJ; Chien KL; Chen MF; Lai LP; Chiang FT
Cardiology; 2001; 95(3):146-50. PubMed ID: 11474160
[TBL] [Abstract][Full Text] [Related]
13. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
Yamanaka K; Takehara N; Murata K; Banno K; Sato T
J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
Tikkanen I; Omvik P; Jensen HA
J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133
[TBL] [Abstract][Full Text] [Related]
15. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group.
Tanser PH; Campbell LM; Carranza J; Karrash J; Toutouzas P; Watts R
Am J Hypertens; 2000 Feb; 13(2):214-8. PubMed ID: 10701823
[TBL] [Abstract][Full Text] [Related]
16. Studies on the magnitude and the mechanism of cough potentiation by angiotensin-converting enzyme inhibitors in guinea-pigs: involvement of bradykinin in the potentiation.
Takahama K; Araki T; Fuchikami J; Kohjimoto Y; Miyata T
J Pharm Pharmacol; 1996 Oct; 48(10):1027-33. PubMed ID: 8953504
[TBL] [Abstract][Full Text] [Related]
17. Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure.
Robinson DM; Curran MP; Lyseng-Williamson KA
Drugs; 2007; 67(9):1359-78. PubMed ID: 17547476
[TBL] [Abstract][Full Text] [Related]
18. [Dry cough in the elderly patients treated with angiotensin converting enzyme inhibitor].
Kaku T; Yamasaki H; Harada N; Tsujino M; Inoue G
Nihon Ronen Igakkai Zasshi; 1991 May; 28(3):365-70. PubMed ID: 1895531
[TBL] [Abstract][Full Text] [Related]
19. The incidence of cough during treatment with angiotensin converting enzyme inhibitors.
Strocchi E; Valtancoli G; Ambrosioni E
J Hypertens Suppl; 1989 Dec; 7(6):S308-9. PubMed ID: 2561146
[TBL] [Abstract][Full Text] [Related]
20. [Efficiency and safety of ACE-inhibiting imidapril in patients with essential hypertension].
Zweiker R; Stoschitzky K; Maier R; Klein W
Acta Med Austriaca; 2002; 29(2):72-6. PubMed ID: 12050950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
